Milton Woman Pleads Guilty to Health Care Fraud
Department of Justice | Fraud | Date Posted: Wednesday, March 25, 2015
Medicaid billed for fictitious office visits
Delaware Consumers Will Soon Receive Payment From Ocwen Mortgage Settlement
Department of Justice | Department of Justice Press Releases | Fraud | Date Posted: Monday, December 8, 2014
First State consumers who are eligible for a direct payment as part of the $7 million settlement Attorney General Beau Biden reached with Ocwen Financial should soon be receiving their checks, Biden announced Monday.
Biden Warns Delaware Consumers and Investors About Ebola Scams
Consumer Protection | Department of Justice | Department of Justice Press Releases | Fraud | Date Posted: Wednesday, October 29, 2014
Attorney General Beau warned Delaware consumers and investors today to be on guard against Ebola-related charitable and investment scams.
Biden reaches phone cramming settlement with AT&T
Consumer Protection | Department of Justice | Department of Justice Press Releases | Fraud | Date Posted: Wednesday, October 8, 2014
Attorney General Beau Biden today announced a nationwide settlement with AT&T Mobility LLC that resolves allegations the company placed charges for third-party services on consumers’ mobile telephone bills that had not been authorized by the consumer, a practice known as “mobile cramming.” The $105 million settlement includes $80 million in refunds to consumers who were “crammed” and a $25 million payment to the Attorneys General and the Federal Communications Commission.
Biden’s Medicaid Fraud Control Unit secures $137,000 for Delaware in national false claims settlement with pharmaceutical company
Department of Justice | Department of Justice Press Releases | Fraud | Date Posted: Thursday, September 25, 2014
Delaware Attorney General Beau Biden has announced that Shire Pharmaceuticals will pay Delaware $137,000 as part of a national settlement with state and federal governments to resolve allegations that the company improperly marketed its drugs for off-label uses. The agreement settles charges that Shire, a Pennsylvania-based company, launched marketing campaigns promoting several drugs for uses for which they had not received FDA approval. Delaware’s $137,000 payment will go to Delaware’s Division of Medicaid and Medical Assistance, as reimbursement for previous Medicaid expenses that were incurred as a result of the drugs being used for off-label purposes.
